Identification of F5 as a Prognostic Biomarker in Patients with Gastric Cancer

Table 2

Multivariate analyses of F5 in the prediction of gastric cancer overall survival.

Variables	HR (95% CI)	value
F5 (high vs. low)	1.533 (1.029, 2.284)	0.036
Age (years) (≥60 vs. <60)	1.581 (1.029, 2.429)	0.037
Pathological M (M1 vs. M0)	1.129 (0.407, 3.132)	0.816
Pathological T (T3/4 vs. T1/2)	1.051 (0.559, 1.978)	0.877
TNM stage
Stage II vs. stage I	2.058 (0.727, 5.830)	0.174
Stage III vs. stage I	2.562 (0.895, 7.330)	0.079
Stage IV vs. stage I	3.014 (0.931, 9.758)	0.066
Radiation therapy (no vs. yes)	1.467 (0.771, 2.791)	0.243
Targeted molecular therapy (no vs. yes)	1.367 (0.861, 2.170)	0.185
Cancer status (yes vs. no)	5.193 (3.296, 8.183)	<0.001

Abbreviations: F5—Coagulation factor V; HR—hazard ratio; CI—confidence interval; T—tumour; N—node; M—metastasis.